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ABSTRACT  The  classification  of  MAP  2  as  a  microtubule-associated  protein  is  based  on  its 
affinity  for microtubules  in vitro and  its filamentous  distribution  in cultured  cells.  We sought 
to determine whether MAP 2 is also able to bind in situ to organelles other than  microtubules. 
For  this  purpose,  primary  cultures  of  rat  brain  cells  were  stained  for  immunofluorescence 
microscopy  with  a  rabbit  anti-MAP  2  antibody  prepared  in  our  laboratory,  as well  as  with 
antibodies to vimentin, an  intermediate filament protein, and to tubulin, the major subunit of 
microtubules.  MAP 2 was present on cytoplasmic fibers in  neurons and in a subpopulation  of 
the  flat  cells  present  in  the  cultures.  Our  observations  were  concentrated  on  the  flat  cells 
because of their suitability for high-resolution  immunofluorescence  microscopy.  Double anti- 
body staining  revealed  co-localization  of  MAP 2 with  both  tubulin  and  vimentin  in  the flat 
cells.  Pretreatment of the cultures with vinblastine resulted in the redistribution  of MAP 2 into 
perinuclear cables that contained vimentin. Tubulin paracrystals were not stained by anti-MAP 
2.  In  cells extracted with digitonin,  the  normal  fibrillar distribution  of MAP 2 was  resistant to 
several  treatments (PIPES buffer plus 10 mM Ca ++, phosphate buffer at pH 7 or 9) that induced 
depolymerization  of  microtubules,  but  not  intermediate  filaments.  Staining  of  the  primary 
brain cells was not observed with  preimmune  serum  nor with  immune serum  adsorbed  prior 
to  use with  pure  MAP 2.  We  detected  MAP 2 on  intermediate  filaments  not only with  anti- 
MAP 2 serum,  but also with  affinity  purified  anti-MAP 2 and with  a monoclonal  anti-MAP 2 
prepared in another laboratory. We conclude from these experiments that material  recognized 
by anti-MAP 2 antibodies  associates  with  both  microtubules  and  intermediate  filaments.  We 
propose that one function  of MAP 2 is to cross-link the two types of cellular filaments. 
Since the introduction of procedures for purifying cytoplasmic 
microtubules (6, 48), it has become evident that these structures 
are composed of numerous polypeptide species.  Tubulin is the 
predominant component of cytoplasmic microtubules.  In ad- 
dition,  numerous proteins  that  appear to be  associated with 
tubulin  have  been discovered.  These  microtubule-associated 
proteins,  or MAPs (53),  have been identified on the basis of 
their affinity for microtubules in vitro (4,  12, 38,  53), and on 
the basis of immunocytochemical data (10,  11,  13,  14, 27, 31, 
41, 50, 51, 52). The MAPs have been implicated in controlling 
microtubule assembly (37, 63).  In addition, at least two MAP 
species,  MAP  2  (25,  30)  and  MAP  1  (61),  represent  free 
fdamentous projections regularly spaced  on the microtubule 
surface. This has given rise  to speculation that these proteins 
may mediate the interaction of microtubules with other organ- 
eUes and may, therefore, be important in microtubule function 
as well as microtubule assembly. Evidence for the binding of 
MAPs in vitro to a variety of structures in addition to micro- 
tubules  has  been  reported  (23,  34,  45,  46,  49,  54),  further 
supporting a role for MAPs in the interaction of microtubules 
with other cellular components. 
MAP 2  has been extensively characterized.  It is the most 
abundant  MAP  species  identified  in  brain  tissue,  its  major 
source.  This  laboratory has  shown that  the protein  may be 
divided into two structural domains (58). One domain contains 
the microtubule binding site and promotes microtubule assem- 
bly. The other, larger domain represents the portion of MAP 
2  observed  as a  projection on the microtubule  surface.  The 
projection domain contains a  binding site  for the regulatory 
subunit  of a  type II cAMP-dependent protein  kinase,  which 
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domain  also  contains  a  site  or  sites  for  binding  of  other 
cytoplasmic organdies. 
Evidence for the binding of MAP 2 in vitro to actin filaments, 
coated  vesicles, and intermediate  filaments has been reported 
(1,  24,  34,  40,  45,  46).  While  these  studies  have  identified 
structures that are capable of interacting with MAP 2  in vitro, 
they leave open the question of which organelles actually bind 
MAP 2  in cells. We initiated our study to resolve this question 
and to further our characterization of the binding domains of 
this  protein.  We  reasoned  that  if  the  cellular  microtubule 
binding site for MAP 2  were dissolved it might be possible to 
identify other organelles to which the MAP bound. We chose 
to work with primary cultures of brain ceils because these cells 
contain MAP  2  in apparently high concentration and include 
a  population  of well-spread cells  that  are  suitable  for high- 
resolution immtmocytochemical techniques (27, 41). We report 
that,  after  dissolution  of microtubules,  MAP  2  is  found  in 
association with intermediate  f'daments, indicating  a  role  for 
MAP  2  in mediating the interaction of microtubules with this 
other class of cellular filament. 
MATERIALS  AND  METHODS 
Anti-MAP 2  Antibodies:  We  prepared  a  rabbit  antibody  to calf 
brain MAP 2 in this laboratory, and used it to immunoprecipitate the MAP 2 
protein kinase complex (55) and to localize MAP 2 by immunofluorescence in 
the rat central nervous system (35) (Miller, P., W. E. Theurkauf, R. B. Vallee, 
and  P.  De CAmilli, manuscript  in preparation).  The MAP 2 immunogen was 
purified by a three-step process designed to insure antigen purity. First, callbrain 
microtubules were purified by four cycles of assembly and disassembly in the 
absence of  glycerol (60). The microtubules were exposed to elevated temperatures 
(90-100°C) to coagulate tubulin, MAP  l, and a variety of minor polypeptides 
species (18, 25, 30). The MAP 2-enriched soluble fraction was finally subjected 
to preparative SDS PAGE. After staining with Coomassie Brilliant Blue R250, 
the MAP 2 doublet (30) was excised from the gel and homogenized with Freund's 
complete adjuvant. A rabbit was injected subcutaneously with ~ 100 #g of MAP 
2 on each of three occasions, and was bled 1 wk after the final injection. 
Affinity-purified anti-MAP 2 was prepared by passage of the immune serum 
over a MAP 2-Sepharose 4B column. The MAP 2 used here was prepared from 
twice-cycled calf brain  microtubules by exposure to elevated temperature  (see 
above).  The  protein  was  conjugated  to  CNBr-activated  Sepharose  4B,  and 
monospecific anti-MAP 2 was eluted from the column with 200 mM glycine at 
pH 2.7 (20). 
Monoclonal mouse anti-porcine brain MAP 2 (27) was the generous gift of 
Jonathan  Izant and Richard Mclntosh (University of Colorado). 
Other Antibodies:  Goat anti-chick brain tubulin andgoat anti-tetanus 
toxin were kindly provided by Dr. Robert Wething (Worcester Foundation for 
Experimental Biology) and Dr. William Habig (National Institutes of Health), 
respectively. Monoclonal mouse anti-vimentin  was purchased from Transfor- 
mation Research, Inc. (Framingham, MA). 
Guinea pig antitubulm was prepared in this laboratory. The immunogen was 
purified by three cycles of assembly and disassembly of calf brain microtubules 
(60), chromatography  on  DEAE  Sephadex  A-50 (59) and  preparative  SDS 
PAGE. The tubulin band was homogenized in phosphate-buffered saline (PBS) 
and emulsified with Freund's Complete Adjuvant. The animal was injected at 
four subcutaneous sites with ~700/~g of  tubulin on each of  eight occasions spaced 
1-2 wk apart. A terminal bleed was performed 1 wk after the final injection of 
tubulm. 
The following were purchased from Cappel Laboratories (Cochranville, PA): 
rhodamine-conjugated IgG fractions of sheep and goat anti-rabbit IgG, fluores- 
cein-conjugated IgG fraction of goat anti-guinea pig IgG, and sheep antiserum 
to goat IgG. The IgG fraction of this antiserum was labeled with fluorescein as 
described (19) to an average molar ratio of fluorescein:lgG of 2.6. Fluorescein- 
labeled goat anti-mouse IgG was acquired from Meloy Laboratories (Springfield, 
VA). 
Primary Rat  Brain Cultures:  Features  ofscvcral  published protocols 
(8,  66,  67) were  adapted  to  produce cultures  with  optimal  survival  of  cells  found 
to  contain MAP  2.  Whole brains  from rats  varying in  age  from 16-d  fetuses  to l- 
d postnatal  were used. The cultures  were grown on glass  coverslips  in 35-ram 
petri  dishes.  The coverslips  were coated with a 1:3  mixture of l  mg/ml poly-L- 
lysine  (Sigma Chemical Co.,  St. Louis, MO; Type VII-B, 35,000 tool  wt):  fctai 
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call serum. Each brain yielded enough ceils for six 22-ram  2 coverslips. 
Freshly dissected brains were rinsed twice in Hanks'  balanced salt solution 
(MA Biologicals, Walkersville, MD) and minced as finely as possible with a 
scalpel in 2 ml of 0.25% trypsin (Gibco Laboratories, Grand Island Biological 
Co., Grand Island, NY). An additional 8 ml of trypsin solution was then added, 
and the minced tissue was triturated gently five times with a 10-ml pipette. This 
suspension was stirred at 37°C for 15 min, at which time 10 ml of high serum 
medium was added (43% each F-12 and Dulbecco's MEM, 8% horse serum, 5% 
fetal  call  serum, penicillin, streptomycin; all  from  Gibco  Laboratories). The 
suspension of  single cells and small clumps of  tissue was triturated gently another 
five times, and was centrifuged for 5 rain at 1,500 g. The pellet was resuspendcd 
in high serum medium by gentle trituration, and 2.5 ml of cell suspension was 
added  to each  coverslip. The  dishes  were then  placed in  a  37°C-incubator 
containing  an atmosphere  of 95%  air,  5%  CO2. After 2 h, the  medium  was 
aspirated and each dish was fed with 2.5 ml of N2 defined medium (7) supple- 
mented with 2% fetal calf serum, penicillin, and streptomycin. The cultures were 
ready for use within 3 or 4 d, and could be maintained for several weeks if fed 
every 3 or 4 d with the N2-based medium. 
Indirect Immunofluorescence Microscopy:  CeiLs  to be stained 
for cytoskeletal proteins were processed in the following manner. Coverslips were 
rinsed twice for 30 s with PBS at 37°C. A 5-rain methanol fLxation  at -20°C was 
performed either immediately following the PBS rinses, or after a subsequent 2- 
rain extraction of the cells in PEM buffer (100 mM PIPES, 1 mM EGTA, 1 mM 
MgSO4) containing 0.005% digitonin (Sigma Chemical Co.). The coverslips were 
rehydrated with PBS and incubated with 10% nonspecific serum obtained from 
the  same  animal  species as the  fluorescent antibodies.  10%  serum  was aLso 
included in subsequent antibody incubations. All antibodies were diluted in PBS, 
and  were  applied  to the  ¢overslips for 30  min each  at  37°C  in  humidified 
chambers. Rabbit  anti-MAP 2 serum was used at a final concentration of 1.0- 
1.3%. Affinity-purified rabbit anti-MAP  2 was used at 8-16 #g/ml.  For some 
experiments, rabbit anti-MAP 2 was used in combination with goat or guinea pig 
antitubulin,  or  with  monoclonal  mouse  antibodies  to  vimentin  or  MAP  2. 
Fluorescent anti-IgG antibodies were used alone or in various combinations, as 
indicated in the figure legends. Thorough PBS washes were performed after each 
antibody step. After the final PBS wash, the coverslips were rinsed with distilled 
water and sealed to slides with elvanol (22). 
For the tetanus toxin experiment, live cells were incubated for 30-rain periods 
at 37°C in three changes of medium containing, sequentially, 10 #g/ml tetanus 
toxin, goat anti-tetanus toxin, and fluorescein-sheep anti-goat lgG. A brief PBS 
rinse followed each step. The cells were then fLxed in methanol, and stained with 
rabbit anti-MAP 2 and rhodamine-sheep anti-rabbit IgG, as described above. 
We observed slides on a Zeiss IM-35 inverted microscope equipped with an 
epifluorescent illuminator, ftuorescein and rhodamine filters, and the following 
Zeiss oil immersion objectives: 40x phase 3 NA 1.0 Apochromat, 63x phase 3 
NA 1.4 Pianapochromat. 
Antibody  Staining  of  Nitrocellulose  Transfers:  Electro- 
phoresis of  protein samples was performed according to the Laemmli (32) method 
on 1.5-mm  thick 7% polyacrylamide geLs. Electrophoretic transfer of  proteins was 
performed by the technique of  Towbin et al. (56) modified as follows for efficient 
transfer of high molecular weight polypeptides. After electrophoresis, the gels 
were soaked for 30 rain in 0.125 M Tris, pH 6.8, 0.1% SDS, 1 mM EDTA,  10 
mM 2-mercaptoethanol and then transferred to nitrocellulose sheets in 0.0125 M 
Tris,  pH  8.5, 0.096 M  glycine, 0.01% SDS, 10  mM 2-mercaptoethanoL The 
transfer  was performed for 16 h at room temperature,  with a noncommercial 
transfer apparatus  and a Pharmacia  DPS destainer power supply (Pharmacia 
Fine Chemicals, Piscataway, N  J) at a constant 36 V and a current that varied 
from 1 to 3 A. This resulted in at least 90% transfer of MAP 2. 
Following transfer,  the  nitrocellulose sheet  was  incubated  for  30  rain  in 
staining buffer (0.05 M Tris, pH 7.4, 0.15 M NaC1, 0.05% Nonidet P-40, 0.25% 
bovine serum albumin-Sigma  Fraction V). The paper was then stained for 3 h 
each  with  rabbit  anti-MAP  2  followed by  rhodamine-goat  anti-rabbit  IgG. 
Antibodies were diluted in staining buffer, which was used to wash the paper 
thoroughly  after  each  antibody  step. Fully  dried  nitrocellulose sheets  were 
illuminated in a darkened room with a pair of ultraviolet lamps (Model UVL-2 l; 
Ultra-Violet  Products,  Inc., San  Gabriel,  CA), and  photographs  were taken 
through a yellow Wratten No.  15 gelatin filter (Eastman Kodak) with Polaroid 
Type 55 P/N film. 
RESULTS 
Characterization of Anti-MAP 2 
Partial  characterization  of our  anti-MAP  2  antibody  has 
been  reported elsewhere (35;  Miller,  P.,  W.  E.  Theurkauf,  R. 
B. Vallee, and P.  De Camilli, manuscript in preparation). The 
antibody stained neurons in sections of mature rat brain, and 
showed particularly bright staining of neuronal dendrites. The FIGURE  1  Immunochemical  detec- 
tion of MAP 2 in  newborn rat brain. 
A brain from a newborn rat was com- 
pletely dissolved by homogenization 
in  hot SDS PAGE sample buffer and 
subjected  to  electrophoresis.  (Lane 
A)  Coomassie  Brilliant  Blue  R250. 
(Lane  B)  A  nitrocellulose  replica of 
the same sample stained with  rabbit 
anti-MAP  2  followed  by  rhodamine 
goat anti-rabbit IgG. 
antibody specifically stained a protein of the molecular weight 
of MAP 2 in whole brain, purified microtubules, and purified 
preparations of MAP 2.  For the present study, we examined 
newborn rat brain tissue by immunocytochemical means (Fig. 
1). It may be observed that only a band at the position of MAP 
2 reacts with the anti-MAP 2 antiserum. 
Immunofluorescent Detection of MAP 2 in 
Primary Cultures of Rat Brain Cells 
The  primary cultures of rat brain cells used  in  this study 
contained  a  variety of morphologically distinct ceils. When 
these cultures were reacted with anti-MAP 2  antibody, only 
selected ceils were  stained. Fig. 2a and b  illustrate the most 
common  MAP  2-positive cells.  These  cells  had  a  neuronal 
morphology, with small soma (10-25  /tm diameter) and nu- 
merous free processes that occasionally extended for >100 #m. 
The  processes  frequently  exhibited  periodic  varicosities.  In 
favorable  images,  distinct fluorescent  fibrils were  visible in 
large, neuronlike cells (Fig. 2c).  Almost all MAP 2-positive 
neuronlike cells were found to possess tetanus toxin receptors 
(not shown) and were probably neurons, therefore (16,  36).  In 
addition to containing cells of neuronal morphology, the cul- 
tures  also contained an abundance  of fiat, well-spread cells, 
some of which stained with anti-MAP 2 (Fig. 2 d). The staining 
of such cells was always found on networks of gently curving 
cytoplasmic fibrils, whose appearance resembled microtubules 
or 10-rim filaments. These cells were negative for tetanus toxin 
receptors  (not  shown),  and  their  identity  is  not  known  at 
present. We observed both MAP 2-positive cell types whether 
unfractionated anti-MAP 2  antiserum,  affinity-purified anti- 
MAP  2,  or monoclonal anti-MAP 2  was used.  Examples of 
such staining may be observed throughout this paper (Figs. 2- 
8). No specific staining of either the neurons or flat cells was 
detected with antiserum preadsorbed with the purified MAP 2 
that was used as the immunogen,  or with preimmune serum 
(not shown). 
Co-localization  of MAP 2 and Tubulin 
The MAP 2-positive flat cells provided an excellent experi- 
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mental system for high-resolution, immunofluorescent location 
of MAP  2,  which was  not  possible with  the  more compact 
neurons. Therefore, our observations focused on the fiat sub- 
population of cells, as described in the remainder of the paper. 
To determine whether MAP 2 co-localized with microtubules, 
the cultures were stained simultaneously with anti-MAP 2 and 
antitubulin. An example of a fiat, MAP 2-positive cell stained 
also with antitubulin is shown in Fig. 3 a  and b. Extensive co- 
localization of the  two  antigens  on  cytoplasmic fibers  was 
observed.  Dividing  MAP  2-positive  cells  were  occasionally 
found.  We  observed co-localization of MAP  2  and  tubulin 
throughout mitosis and cytokinesis (Fig. 3 c-f). 
Uncoupling of MAP 2- Tubulin Co-Localization 
The  anti-MAP  2  staining  patterns  shown  in  Fig.  3  are 
characteristic of microtubules. To determine the cellular loca- 
tion of MAP 2 in the absence of microtubules, we employed 
two approaches. First, the cultures were exposed to vinblastine 
sulfate for several hours prior to fixation and antibody staining. 
Antitubulin staining (not shown) revealed the absence of mi- 
crotubules  in  the  fiat ceils, and  the  appearance  of brightly 
staining tubulin paracrystals, as is characteristic of  cells exposed 
to this drug. Thin-section electron microscopy of these cultures 
similarly revealed the complete absence of microtubules (not 
shown).  Fig. 4  shows  an example of a  flat cell that  showed 
positive staining with anti-MAP 2.  The single, striking para- 
crystal  in  this  cell  was  readily  detected  by  phase-contrast 
microscopy (Fig. 4a).  However,  the  antibody conspicuously 
failed to stain the paracrystal. Instead, a sinuous cable of bright 
fluorescence surrounding the nucleus was observed (Fig. 4 b). 
This  pattern of staining was clearly not consistent with that 
found for tubulin. Rather, it was consistent with that expected 
for certain classes of intermediate filaments. An intermediate 
fdamentlike distribution of MAP 2 was also observed in ceils 
exposed  to  colchicine (not  shown),  and  was  apparent  with 
vinblastine or colchicine incubations ranging from  1 to 24 h. 
Thus, our results appeared to reveal a  second binding site for 
MAP 2 in cells, one associated with intermediate filaments. 
As an independent approach to eliminate microtubules, the 
primary brain cells were extracted with digitonin under con- 
ditions known  to  result  in  the  disassembly of microtubules. 
The cells were then fixed and double-stained for tubulin and 
MAP 2, as shown in Fig. 5. MAP 2 and tubulin co-localized on 
cytoplasmic fibrils in cells extracted with PIPES buffer (Fig. 
5a  and  b),  which  preserves  microtubules.  Both  phosphate 
buffers (Fig. 5f and h) and PIPES buffer with  10 mM Ca  ++ 
(Fig.  5d)  dissolved  microtubules,  as judged  by  antitubulin 
staining.  However,  the  same  cells  still exhibited  a  fibrillar 
pattern  of  staining  with  anti-MAP  2  (Fig.  5 c,  e,  and  g), 
indicating the existence of a  nonmicrotubule binding site for 
MAP 2 in these cells. The fibrillar  nature of the staining pattern 
and its stability in the extracted cells is again consistent with 
localization of MAP 2 on intermediate filaments. 
Co-localization  of MAP 2 and Vimentin 
To  determine  directly whether  MAP  2  co-localized with 
intermediate  filaments,  cells were  double-stained with  anti- 
bodies to vimentin and MAP 2 (Fig. 6). Extensive co-localiza- 
tion of MAP 2  and vimentin on cytoplasmic fibrils was  ob- 
served.  In vinblastine-treated cultures (Fig. 7),  we again ob- 
served co-localization of vimentin and  MAP 2,  but  now  on 
cables characteristic of intermediate filaments in cells exposed 
to the drug. 
MAP  2  Binds to Microtubules and Intermediate Filaments  1525 FIGURE  2  Immunofluorescent detection of MAP  2 in two morphological classes of primary newborn rat brain cells. Cells were 
stained with affinity purified anti-MAP 2 followed by rhodamine-sheep anti-rabbit IgG. (a) Phase-contrast image of a typical field 
of cells. (b) Corresponding immunofluorescent image revealing presence of MAP 2 in cells of neuronal morphology. (c) Cells of 
neuronal morphology showing anti-MAP 2 staining of distinct cytoplasmic fibers. (d) Flat cell of nonneuronal morphology showing 
anti-MAP 2 staining on cytoplasmic fibers. Bars, I0/~m. (a and  b) x  1,000. (c) x  2,100. (d) x  800. 
Comparison  of Polyclonal and Monoclonal Anti- 
MAP2 
To determine whether the results obtained were unique to 
our anti-MAP 2 antibody preparation, vinblastine-treated cells 
were double-labeled with our polyclonal rabbit antibody and 
a monoclonal antibody prepared by Izant and McIntosh (27). 
The results of this comparison are shown in Fig. 8. It is clear 
that both antibody preparations stained intermediate filament 
cables, but not tubulin paracrystals, in the flat primary brain 
cells. 
DISCUSSION 
MAP 2 has been classified as a MAP primarily on the basis of 
its  affinity for microtubules  in vitro (4,  38,  53).  In addition, 
antibodies to this protein have been found to stain cytoplasmic 
fibers in a  limited number of cultured cell types (27,  31, 41, 
57).  The conclusion that these  fibers were microtubules was 
based  on co-localization of the  immunoreactive species with 
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tubulin  (27) and abolition of the  fibrous staining  pattern  by 
antimicrotubule drugs (27, 31). Here we report that in cultured 
brain  cells  an  anti-MAP  2  antibody  stained  fibrils  that  co- 
localized with both microtubules (see Fig. 3) and intermediate 
filaments  (see Fig. 6).  The intermediate  fflamentlike staining 
pattern persisted after dissolution ofmicrotubules in living cells 
by antimicrotubule drugs (see Figs. 4, 7, and 8), or in cytoskel- 
etal  preparations  by appropriate  buffers  (see  Fig.  5).  These 
results indicated that material cross-reactive with MAP 2 may 
be  associated  with  intermediate  fdaments,  as  well  as  with 
microtubules. 
Specificity of the Anti-MAP 2 Antibody 
It is possible that these results simply reflect the presence in 
our anti-MAP 2 preparation of contaminating antibodies spe- 
cific  for an  intermediate  fdament  protein.  We  consider  this 
quite unlikely since both affinity purified anti-MAP 2 (see Fig. 
4 b) and an independently prepared monoclonal anti-MAP 2 
(see Fig. 8 b) stained intermediate  filaments.  In addition, nei- FIGURE  3  Co-localization of MAP 2 and tubulin.  Flat, MAP 2-positive cells are shown in interphase (a and  b), telophase (c and 
d), and  metaphase (e and  f).  Cells were incubated with  rabbit anti-MAP 2 serum  plus either goat (b and  f)  or guinea pig (d) 
antiserum  to  tubulin.  Primary antibodies were then  stained simultaneously with  either rhodamine-sheep anti-rabbit  IgG  plus 
fluorescein-sheep anti-goat IgG, or with  rhodamine-goat anti-rabbit IgG plus fluorescein-goat anti-guinea pig IgG.  (a,  c, and  e) 
anti-MAP 2; (b,  d, and  f)  antitubu[in. Bars, 10/~m. (a and  b)  X 800.  (c and  d)  x  1,100. (e and  f)  X  1,200. 
FIGURE 4  Effect  of 
vinblastine  on  MAP  2 
staining.  A  primary 
brain  cell  culture  was 
treated with 10/~M vin- 
blastine sulfate for 15 h 
before  being  stained 
with  affinity  purified 
anti-MAP 2 and  rhoda- 
mine  sheep-anti-rabbit 
IgG. (a) Phase contrast. 
(b)  Anti-MAP 2. Imme- 
diately  above  the  nu- 
cleus is a prominent tu- 
bulin  paracrystal  easily 
visualized  by  phase 
contrast,  but  not 
stained  by  the  anti- 
body.  Bar,  10  #m.  x 
1,300. 
ther immune serum adsorbed prior to use with pure MAP 2, 
nor preimmune serum-stained cytoplasmic fdaments. 
This indicates that the intermediate filament-associated an- 
tigen  recognized by anti-MAP  2  is  truly  cross-reactive with 
MAP 2. Nonetheless, it is possible that this antigen represents 
a protein quite distinct from MAP 2, but which is immunolog- 
icaUy cross-reactive due  to limited amino acid sequence ho- 
mology.  Several  examples  of distinct,  but  immunologically 
cross-reactive cytoskeletal proteins  have been reported  (3,  5, 
39, 42). Indeed, it has been found that MAP 2 itself reacts with 
an antispectrin antibody (15). 
Thus, it is possible that we have identified an intermediate 
fdament protein which shares one or more antigenic sites with 
MAP 2, but is otherwise distinct.  However, several considera- 
tions  lead  us  to  believe  that  MAP  2  itself  is  the  antigen 
associated with intermediate fdaments. First, the only antigenic 
species detected by our antibody in a mixture of total newborn 
rat brain  proteins has a  mobility in SDS PAGE identical to 
that of MAP 2 (see Fig.  1). Second, the antibody stained only 
a limited number of the fiat cells in these cultures (10% or less). 
Among these cells, unambiguous staining of microtubules was 
observed  during  mitosis,  while  intermediate  filaments  were 
clearly stained after vinblastine treatment. Thus, if two distinct, 
cross-reactive proteins exist in primary brain cells, both would 
be present in the same small subpopulation of fiat cells. While 
such  a  coincidence is  conceivable,  it  seems  highly unlikely. 
Finally, we also observed co-localization of MAP 2 with both 
BLOOM AND VALLEE  MAP 2 Binds to Microtubules and Intermediate Filaments  1527 FIGURE  .5  Presence of MAP 2 on cytoplasmic 
fibers in isolated cytoskeletons lacking micro- 
tubules.  Cells  were extracted  with  digitonin 
as described in Materials and Methods, incu- 
bated  for  15  min  at  room  temperature  in 
various buffers, fixed, and treated with rabbit 
anti-MAP 2 serum and guinea pig antitubulin, 
followed  by  rhodamine goat anti-rabbit  IgG 
and fluorescein-goat anti-guinea pig IgG.  (a, 
c, e, and g) Anti-MAP 2 staining; (b, d,  f, and 
h)  Antitubulin  staining.  (a  and  b)  control 
buffer:  100 mM  PIPES, pH  6.6,  1 mM  MgSO4 
and 1 mM EGTA;  (c and  d), the same, plus 10 
mM CaCI2; ( eand f) 100 mM phosphate buffer 
at pH 7; (gand  h), 100 mM phosphate buffer 
at pH 9.  Bar, 10 p.m. x  700. 
microtubules  and intermediate  fdaments in the  BI04 neuro- 
blastoma cell  line.  In this  homogeneous population of cells, 
only a single protein of Mr 270,000 reacted with anti-MAP 2, 
further supporting our contention that a single protein species 
binds to both microtubules and intermediate fdaments (G. S. 
Bloom and R. B. Vallee, unpublished observations). 
Although  other  laboratories  have  used  anti-MAP  2  anti- 
bodies for immunofluorescence microscopy on cultured  ceils 
(27,  31, 41,  57),  the association of MAP 2  with intermediate 
filaments has not been reported until now. Detection of this 
association may depend on the use of an appropriate combi- 
nation  of cultured  cell  system  and  experimental  protocols. 
Indeed,  we demonstrate here that a  monoclonal anti-MAP 2 
antibody (27)  independently  prepared  in another  laboratory 
can  stain  intermediate  fdaments  in  our  vinblastine-treated 
primary brain cells (see Fig. 8). 
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Intracellular  Functions  of  MAP  2 
Immunocytochemical, electron microscopic, and physiolog- 
ical evidence  (2,  17,  21,  26,  33,  44,  47)  have pointed  to an 
association between microtubules and intermediate fdaments. 
In particular,  double immunofluorescence microscopy has re- 
vealed extensive co-localization of microtubules with desmin 
fdaments in chicken gizzard cells (21), with vimentin f'daments 
in fibroblasts (2) and with glial filaments in primary astrocytes 
(G. S. Bloom, R. B. Vallee, and R. Liem, unpublished obser- 
vations).  These findings suggest that microtubules and inter- 
mediate fdaments may be commonly connected to one another 
in cells,  presumably by cross-linking proteins. 
Recently, Wiche and co-workers (43,  64) proposed that  a 
high molecular weight MAP-like protein cross-links microtu- 
bules  and  intermediate  fdaments  in  numerous  varieties  of cultured ceils. However, subsequent studies in the same labo- 
ratory revealed that the protein, now known as "plectin," has 
an  intracellular distribution  that  is  markedly  distinct  from 
microtubules and intermediate t'daments (65).  Therefore, we 
feel it is unlikely that plectin acts as a cross-linker. In contrast, 
our finding that MAP 2 can co-localize with both microtubules 
and intermediate filaments indicates that this protein, in par- 
ticular, is responsible for the observed interactions of the two 
classes of cytoplasmic fibers. Since MAP 2 may not be univer- 
sally distributed in cells (27, 41,  57),  it is possible that other 
unidentified proteins also serve this function. 
Although MAP 2  was  found to be co-distributed with vi- 
mentin,  we do not know whether vimentin is the only inter- 
mediate filament protein in the MAP 2-positive, fiat brain cells. 
For this reason, we are not yet certain whether MAP 2 binds 
directly to vimentin itself, or to another intermediate filament 
protein with a  similar intracellular distribution. Further bio- 
chemical work will be required to determine the specific inter- 
mediate fdament proteins that are able to bind to MAP 2, and 
to define the relevant binding domains on MAP 2 (cf. reference 
58). 
Our data represent the first demonstration that one role for 
MAP 2 in cells is to mediate interactions of microtubules and 
intermediate t'daments. Whether this is the only cellular func- 
tion of MAP 2 is not clear, since the protein is most abundant 
in vivo in neuronal dendrites (35; Miller, P., W. E. Theurkauf, 
R. B. Vallee, and P. De Camilli, manuscript in preparation), 
which  contain  abundant  microtubules, but  few  intermediate 
FIGURE  6  Co-localiza- 
tion  of  MAP  2  and 
vimentin.  Cells  were 
stained with rabbit anti- 
MAP 2 serum and mon- 
oclonal  mouse  antivi- 
mentin,  followed  by 
rhodamine  goat  anti- 
rabbit  IgG  and  flu- 
orescein-goat  anti- 
mouse  IgG.  (a)  Anti- 
MAP 2 staining; (b) An- 
tivimentin staining. Bar, 
10 gm. X 900, 
FIGURE  8  Detection of MAP 2 on intermediate-filament cables in 
vinblastine-treated cells by polyclonal and monoclonal antibodies. 
Cells were treated  for 18  h  with  10 gM vinblastine sulfate  before 
being stained with rabbit anti-MAP 2 serum and monoclonal mouse 
anti-MAP 2, followed by a combination of goat anti-rabbit IgG and 
fluorescein goat anti-mouse IgG. (a) Phase contrast; (b) Rabbit anti- 
MAP 2 serum;  (c)  Monoclonal mouse anti-MAP 2 antibody. Bar, 10 
gin. x  900. 
FIGURE  7  Co-localization of MAP 2 and vimentin on  perinuclear cables in vinblastine-treated cells. Cells were treated for 17 h 
with  10 gM vinblastine sulfate.  They were then  stained with  rabbit antiserum  to MAP 2 and  monoclonal  mouse antivimentin, 
followed  by  rhodamine  goat  anti-rabbit  IgG  and  fluorescein  goat  anti-mouse  IgG.  (a)  Phase  contrast.  (b)  Anti-MAP  2.  (c) 
Antivimentin.  Bar, 10/~m.  x  800. 
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tubules and intermediate filaments may be only one role of the 
protein, and that other cellular functions remain to be defined. 
Recent work by Izant and co-workers (28,  29) has suggested 
that the 210,000-dalton  MAP identified in HeLa cells (9, 62) 
may be heterogeneous with regard to cellular distribution and 
function. Similarly, MAP 2 may be a complex protein species, 
individual components of which bind to a  variety of cellular 
organelles.  Indeed,  the  size heterogeneity of MAP  2  in SDS 
PAGE (30) may signify functional heterogeneity as well. It is 
also possible that the binding specificity of MAP 2 is regulated 
by posttranslational modification. For example, phosphoryla- 
tion  of  MAP  2  by  its  associated  cAMP-dependent  protein 
kinase (55,  60)  or by other protein kinases could potentially 
regulate whether MAP 2 binds to intermediate filaments or to 
other structures. 
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